KVUE
Kenvue Inc. NYSE Listed May 4, 2023$17.73
After hrs
$17.59
+0.00%
Mkt Cap $34.0B
52w Low $14.02
33.3% of range
52w High $25.17
50d MA $17.64
200d MA $17.87
P/E (TTM)
22.6x
EV/EBITDA
13.8x
P/B
3.1x
Debt/Equity
0.8x
ROE
13.7%
P/FCF
19.1x
RSI (14)
—
ATR (14)
—
Beta
0.57
50d MA
$17.64
200d MA
$17.87
Avg Volume
31.8M
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
1 Kenvue Way · Summit, NJ 07901 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | TNS | 0.27 | 0.25 | -7.4% | — | — | — | — | — | — | — | — |
| Feb 17, 2026 | TNS | 0.22 | 0.27 | +21.2% | 18.41 | +0.7% | +2.6% | +1.4% | +1.7% | +2.9% | +3.3% | — |
| Nov 3, 2025 | TNS | 0.26 | 0.28 | +7.6% | 16.14 | -0.1% | -1.1% | +0.6% | +2.0% | +4.6% | +3.9% | — |
| Aug 7, 2025 | TNS | 0.28 | 0.29 | +2.9% | 21.76 | -0.6% | -1.9% | -2.5% | +0.6% | -0.2% | -3.2% | — |
| May 8, 2025 | TNS | 0.23 | 0.24 | +5.5% | 24.06 | -0.0% | +1.6% | -0.2% | -1.7% | -3.6% | -0.7% | — |
| Feb 6, 2025 | TNS | 0.26 | 0.26 | +0.0% | 19.80 | +0.5% | +1.9% | +3.9% | +5.6% | +5.9% | +8.3% | — |
| Nov 7, 2024 | TNS | 0.27 | 0.28 | +2.8% | 22.97 | -0.4% | +3.1% | +3.5% | +3.0% | +0.7% | +2.8% | — |
| Aug 6, 2024 | TNS | 0.28 | 0.32 | +16.1% | 20.86 | -0.8% | -1.2% | +1.9% | +0.8% | +1.1% | +2.3% | — |
| May 7, 2024 | TNS | 0.25 | 0.28 | +10.2% | 20.08 | +0.0% | +1.8% | +2.3% | +2.3% | +1.4% | +2.7% | — |
| Feb 8, 2024 | TNS | 0.28 | 0.31 | +9.5% | 19.33 | -0.7% | +0.0% | +1.3% | -0.4% | -1.2% | -1.4% | — |
| Oct 26, 2023 | TNS | 0.30 | 0.31 | +3.3% | 18.69 | -0.4% | -2.6% | -0.3% | -0.5% | +1.0% | +2.9% | — |
| Jul 20, 2023 | TNS | 0.29 | 0.32 | +10.3% | 24.51 | +0.6% | -2.0% | -1.4% | +2.5% | +0.7% | -1.1% | — |
| Jun 2, 2023 | AMC | 0.32 | 0.19 | -40.6% | 25.55 | +0.1% | -1.6% | -1.5% | -1.8% | -1.7% | -1.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | Citigroup | Maintains | Neutral → Neutral | — | $17.38 | $17.35 | -0.2% | -0.5% | +0.5% | +1.3% | +1.2% | -0.5% |
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $17.26 | $17.18 | -0.5% | +0.7% | +0.2% | +1.2% | +2.0% | +1.9% |
| Apr 7 | UBS | Maintains | Neutral → Neutral | — | $17.30 | $17.25 | -0.3% | -3.3% | +0.2% | +0.8% | +0.3% | -0.2% |
| Mar 6 | Barclays | Maintains | Equal Weight → Equal Weight | — | $18.25 | $18.09 | -0.9% | +0.8% | -0.5% | -1.6% | -3.3% | -4.7% |
| Feb 18 | UBS | Maintains | Neutral → Neutral | — | $18.41 | $18.54 | +0.7% | +2.6% | +1.4% | +1.7% | +2.9% | +3.3% |
| Feb 18 | Citigroup | Maintains | Neutral → Neutral | — | $18.41 | $18.54 | +0.7% | +2.6% | +1.4% | +1.7% | +2.9% | +3.3% |
| Feb 18 | Canaccord Genuity | Maintains | Hold → Hold | — | $18.41 | $18.54 | +0.7% | +2.6% | +1.4% | +1.7% | +2.9% | +3.3% |
| Jan 30 | Jefferies | Downgrade | Buy → Hold | — | $17.20 | $17.19 | -0.1% | +1.2% | +1.0% | +2.3% | +4.7% | +5.1% |
| Nov 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.88 | $16.74 | -0.8% | -0.7% | -0.9% | -1.2% | -0.7% | -1.3% |
| Oct 29 | Canaccord Genuity | Downgrade | Buy → Hold | — | $14.51 | $14.34 | -1.2% | -1.4% | -1.9% | -1.0% | +11.2% | +10.1% |
| Oct 27 | Jefferies | Maintains | Buy → Buy | — | $15.00 | $15.10 | +0.7% | +0.5% | -3.3% | -4.6% | -5.1% | -4.2% |
| Oct 10 | JP Morgan | Maintains | Overweight → Overweight | — | $16.84 | $16.85 | +0.1% | -1.1% | -3.7% | -4.1% | -3.4% | -16.2% |
| Oct 9 | Citigroup | Maintains | Neutral → Neutral | — | $16.08 | $16.17 | +0.6% | +4.7% | +3.5% | +0.9% | +0.4% | +1.1% |
| Oct 8 | BofA Securities | Maintains | Buy → Buy | — | $16.22 | $16.10 | -0.7% | -0.9% | +3.8% | +2.7% | +0.0% | -0.4% |
| Oct 8 | UBS | Maintains | Neutral → Neutral | — | $16.22 | $16.10 | -0.7% | -0.9% | +3.8% | +2.7% | +0.0% | -0.4% |
| Oct 2 | Goldman Sachs | Maintains | Neutral → Neutral | — | $15.85 | $15.92 | +0.4% | -0.8% | -0.3% | -1.0% | +2.3% | +1.5% |
| Oct 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.23 | $16.22 | -0.1% | -2.3% | -3.1% | -2.6% | -3.3% | -0.1% |
| Sep 26 | Rothschild & Co | Upgrade | Neutral → Buy | — | $16.17 | $16.42 | +1.5% | +1.5% | +1.1% | +0.4% | -2.0% | -2.7% |
| Sep 23 | Evercore ISI | Maintains | In Line → In Line | — | $16.97 | $17.90 | +5.5% | +1.6% | -0.6% | -4.7% | -3.2% | -3.7% |
| Sep 16 | Citigroup | Maintains | Neutral → Neutral | — | $18.25 | $18.35 | +0.5% | -0.7% | +0.5% | -0.8% | +0.5% | -7.0% |
| Sep 8 | Evercore ISI | Maintains | In Line → In Line | — | $18.62 | $18.75 | +0.7% | -1.0% | +1.3% | -0.8% | +1.2% | +2.0% |
| Aug 8 | Canaccord Genuity | Maintains | Buy → Buy | — | $21.76 | $21.62 | -0.6% | -1.9% | -2.5% | +0.6% | -0.2% | -3.2% |
| Aug 8 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $21.76 | $21.62 | -0.6% | -1.9% | -2.5% | +0.6% | -0.2% | -3.2% |
| Jul 25 | JP Morgan | Maintains | Overweight → Overweight | — | $22.50 | $22.46 | -0.2% | +1.5% | -0.6% | -1.5% | -3.6% | -4.7% |
| Jul 17 | UBS | Maintains | Neutral → Neutral | — | $21.85 | $21.83 | -0.1% | +0.0% | +0.7% | +1.3% | +3.8% | +3.2% |
| Jul 15 | Citigroup | Maintains | Neutral → Neutral | — | $21.82 | $21.58 | -1.1% | -2.0% | +0.1% | +0.1% | +0.8% | +1.4% |
| Jul 15 | BofA Securities | Maintains | Buy → Buy | — | $21.82 | $21.58 | -1.1% | -2.0% | +0.1% | +0.1% | +0.8% | +1.4% |
| Jul 15 | Barclays | Maintains | Equal Weight → Equal Weight | — | $21.82 | $21.58 | -1.1% | -2.0% | +0.1% | +0.1% | +0.8% | +1.4% |
| May 12 | Barclays | Maintains | Equal Weight → Equal Weight | — | $24.44 | $24.26 | -0.7% | -1.8% | -3.2% | -5.1% | -2.3% | -1.1% |
| May 9 | UBS | Maintains | Neutral → Neutral | — | $24.06 | $24.05 | -0.0% | +1.6% | -0.2% | -1.7% | -3.6% | -0.7% |
| May 9 | Citigroup | Maintains | Neutral → Neutral | — | $24.06 | $24.05 | -0.0% | +1.6% | -0.2% | -1.7% | -3.6% | -0.7% |
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $22.09 | $22.37 | +1.3% | +2.8% | +3.7% | +2.9% | +5.9% | +0.8% |
| Apr 14 | Citigroup | Maintains | Neutral → Neutral | — | $22.09 | $22.37 | +1.3% | +2.8% | +3.7% | +2.9% | +5.9% | +0.8% |
| Mar 27 | Barclays | Maintains | Equal Weight → Equal Weight | — | $23.40 | $23.46 | +0.3% | +0.4% | +1.3% | +2.5% | +2.1% | +2.0% |
| Mar 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $23.42 | $23.43 | +0.0% | -1.6% | -1.0% | +0.0% | +2.1% | +0.3% |
| Feb 24 | Piper Sandler | Maintains | Overweight → Overweight | — | $23.32 | $23.30 | -0.1% | -0.1% | +0.2% | -0.4% | -0.8% | +1.2% |
| Feb 7 | UBS | Maintains | Neutral → Neutral | — | $19.80 | $19.90 | +0.5% | +1.9% | +3.9% | +5.6% | +5.9% | +8.3% |
| Feb 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $19.80 | $19.90 | +0.5% | +1.9% | +3.9% | +5.6% | +5.9% | +8.3% |
| Feb 3 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $21.29 | $21.18 | -0.5% | -0.3% | -2.3% | -2.6% | -7.0% | -5.2% |
| Jan 17 | Barclays | Maintains | Equal Weight → Equal Weight | — | $21.19 | $21.20 | +0.0% | -0.4% | -1.8% | -2.1% | -2.1% | -1.9% |
| Jan 16 | UBS | Maintains | Neutral → Neutral | — | $20.85 | $20.74 | -0.5% | +1.6% | +1.2% | -0.2% | -0.5% | -0.5% |
| Jan 15 | Citigroup | Maintains | Neutral → Neutral | — | $21.03 | $21.19 | +0.8% | -0.9% | +0.8% | +0.3% | -1.1% | -1.3% |
| Jan 6 | Piper Sandler | Upgrade | Neutral → Overweight | — | $21.20 | $21.60 | +1.9% | -0.4% | -0.7% | -0.5% | -1.7% | -1.1% |
| Dec 12 | Deutsche Bank | Downgrade | Buy → Hold | — | $22.22 | $21.98 | -1.1% | +0.5% | -0.0% | -0.7% | -0.8% | -3.2% |
| Oct 22 | BofA Securities | Maintains | Buy → Buy | — | $22.92 | $22.55 | -1.6% | +0.0% | -0.7% | +0.2% | -1.2% | -0.2% |
| Oct 11 | JP Morgan | Maintains | Overweight → Overweight | — | $21.32 | $21.39 | +0.3% | +0.7% | +1.3% | +2.1% | +1.9% | +0.6% |
| Sep 24 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $23.02 | $23.03 | +0.0% | +0.4% | -0.1% | +0.5% | +1.0% | +0.5% |
| Sep 23 | Piper Sandler | Maintains | Neutral → Neutral | — | $23.02 | $22.83 | -0.8% | +0.0% | +0.4% | -0.1% | +0.5% | +1.0% |
| Aug 7 | Deutsche Bank | Maintains | Buy → Buy | — | $20.86 | $20.69 | -0.8% | -1.2% | +1.9% | +0.8% | +1.1% | +2.3% |
| Aug 7 | JP Morgan | Maintains | Overweight → Overweight | — | $20.86 | $20.69 | -0.8% | -1.2% | +1.9% | +0.8% | +1.1% | +2.3% |
No insider trades available.
8-K · 2.02
!! High
Kenvue Inc. -- 8-K 2.02: Earnings Results
Kenvue reported Q1 2026 earnings results on May 7, 2026, with detailed financial performance metrics available in the accompanying press release filing.
May 7
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
KVUE promoted an internal executive to interim CFO with a $125,000 monthly stipend, signaling either financial instability or a planned succession that investors should monitor for permanent leadership clarity.
Apr 15
8-K
Kenvue Inc. -- 8-K Filing
Kenvue's restructuring cost estimates carry significant uncertainty due to varying jurisdictional requirements, potentially creating financial volatility for investors depending on actual implementation expenses.
Feb 17
8-K · 5.02
!!! Very High
Kenvue Inc. -- 8-K 5.02: Executive Change
Kenvue appointed Amit Banati as principal financial officer while he simultaneously resigned as CFO, indicating a potential transition or restructuring of the finance leadership role.
Feb 12
Data updated apr 25, 2026 6:13pm
· Source: massive.com